会員登録をお勧めします。無料です。

WHITE CROSSは若手歯科医師の3人に1人が登録する、国内最大級の歯科向け情報サイトです。
歯科医師のみならず、医療関係者の皆様へ最新の臨床・経営、ニュース、イベント情報などを配信しています

無料の会員登録で、以下の機能がご利用いただけるようになります

お役立ちツール

コミュニティ

ドクタートークや記事へのコメント、統計への参加や結果参照など、ユーザー様参加型コンテンツへアクセスできます。

論文検索

論文検索

日本語AIで読むPubMed論文検索機能へ自由にアクセス可能です。

ライブセミナー

ライブセミナー

LIVEセミナーやVODによるWebセミナーへの視聴申し込みが可能です。
※別途視聴費用のかかるものがあります。

日本語AI翻訳でPubMed論文検索 | WHITE CROSS 歯科医師向け情報サイト

日本語AIでPubMedを検索

PubMedの提供する医学論文データベースを日本語で検索できます。AI(Deep Learning)を活用した機械翻訳エンジンにより、精度高く日本語へ翻訳された論文をご参照いただけます。
Arch. Toxicol..2020 Jun;94(6):2207-2224. 10.1007/s00204-020-02736-z. doi: 10.1007/s00204-020-02736-z.Epub 2020-04-22.

Performance of high-throughput CometChip assay using primary human hepatocytes: a comparison of DNA damage responses with in vitro human hepatoma cell lines.

  • Ji-Eun Seo
  • Qiangen Wu
  • Matthew Bryant
  • Lijun Ren
  • Qiang Shi
  • Timothy W Robison
  • Nan Mei
  • Mugimane G Manjanatha
  • Xiaoqing Guo
PMID: 32318794 DOI: 10.1007/s00204-020-02736-z.

抄録

Primary human hepatocytes (PHHs) are considered the "gold standard" for evaluating hepatic metabolism and toxicity of xenobiotics. In the present study, we evaluated the genotoxic potential of four indirect-acting (requiring metabolic activation) and six direct-acting genotoxic carcinogens, one aneugen, and five non-carcinogens that are negative or equivocal for genotoxicity in vivo in cryopreserved PHHs derived from three individual donors. DNA damage was determined over a wide range of concentrations using the CometChip technology and the resulting dose-responses were quantified using benchmark dose (BMD) modeling. Following a 24-h treatment, nine out of ten genotoxic carcinogens produced positive responses in PHHs, while negative responses were found for hydroquinone, aneugen colchicine and five non-carcinogens. Overall, PHHs demonstrated a higher sensitivity (90%) for detecting DNA damage from genotoxic carcinogens than the sensitivities previously reported for HepG2 (60%) and HepaRG (70%) cells. Quantitative analysis revealed that most of the compounds produced comparable BMD values among the three types of hepatocytes, while PHHs and HepaRG cells produced similar BMD values. Evidence of sex- and ethnicity-related interindividual variation in DNA damage responses was also observed in the PHHs. A literature search for in vivo Comet assay data conducted in rodent liver tissues demonstrated consistent positive/negative calls for the compounds tested between in vitro PHHs and in vivo animal models. These results demonstrate that CometChip technology can be applied using PHHs for human risk assessment and that PHHs had higher sensitivity than HepaRG cells for detecting genotoxic carcinogens in the CometChip assay.